Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth

Keiichi Kondo, William Y Kim, Mirna Lechpammer et al. · 2003

Read Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth by Keiichi Kondo, William Y Kim, Mirna Lechpammer et al. (2003) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pbio-0000083.txt.

Description

Keiichi Kondo, William Y. Kim, Mirna Lechpammer, and their team reported a cancer finding in PLOS Biology in 2003. Some kidney tumors grow after the VHL gene is lost. That loss lets a protein called HIF2α build up and push tumor growth forward.

The authors asked a sharp question: is HIF2α the main driver, or just one of many? Their tests show that blocking HIF2α alone is enough to stop these tumors from growing. That narrows a complex pathway to one key target. For drug research, the message is direct. A treatment that lowers HIF2α action might help patients whose tumors lack working VHL.

Catalog record

CREATORKeiichi Kondo, William Y Kim, Mirna Lechpammer et al.
YEAR2003
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pbio.0000083

Browse the full library · About the Tower of Babel